FindTrial
Sign In

To compare Carbetocin with Oxytocin in Caesarean section for prevention of Post-partum haemorrhage(PPH) at a tertiary Institute: A randomised controlled study

Effectiveness of Carbetocin in Caesarean section for prevention of Post-partum haemorrhage(PPH) in comparison with Oxytocin at a tertiary Institute: A randomised controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/041583
Enrollment
346
Registered
2022-04-01
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Injection Carbetocin 100 microgram : 173 women will be receiving interventional drug Injection carbetocin 100 microgram IV bolus slowly immediately after delivery. Control Intervention1

Sponsors

RIMS Imphal Golden Jubilee research Initiative
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Term Pregnant women reporting to the department of Obstetrics & Gynaecology who will be undergoing caesarean section and giving informed consent in the Regional Institute of Medical Sciences, a tertiary care centre of Imphal, Manipur

Exclusion criteria

Exclusion criteria: Presence of Hypertension, antepartum haemorrhage, fibroid uterus or history of myomectomy, cardiac, renal or liver diseases, epilepsy, bleeding disorders, general anaesthesia and history of hypersensitivity to any drugs.

Design outcomes

Primary

MeasureTime frame
To compare the amount of blood loss as well as the uterine tone following carbetocin and oxytocin in caesareansectionTimepoint: Blood loss, Uterine tone and Vitals are monitored immediately, 2 hours and 24 hours after delivery—

Secondary

MeasureTime frame
To assess the efficacy of the drugs in terms of additional interventions needed and drop in haemoglobinTimepoint: On admission and 24 hours after delivery—

Countries

India

Contacts

Public ContactRanjeeta Angomchanu

Regional Institute of Medical Sciences

pratimadutta09@gmail.com9612001318

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026